477 related articles for article (PubMed ID: 28199833)
1. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
2. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
4. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
[TBL] [Abstract][Full Text] [Related]
7. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
9. Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model.
Tomita Y; Ozawa N; Miwa Y; Ishida A; Ohta M; Tsubota K; Kurihara T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771164
[TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Andreoli CM; Miller JW
Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Efficacy of a Novel Acetylated Tetrapeptide in Animal Models of Age-Related Macular Degeneration.
Koo HC; Baek YY; Choi JS; Kim YM; Sung B; Kim MJ; Kim JG; You JC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918777
[TBL] [Abstract][Full Text] [Related]
13. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
16. The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.
Zeng M; Shen J; Liu Y; Lu LY; Ding K; Fortmann SD; Khan M; Wang J; Hackett SF; Semenza GL; Campochiaro PA
J Mol Med (Berl); 2017 Apr; 95(4):417-429. PubMed ID: 28004126
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress promotes ocular neovascularization.
Dong A; Xie B; Shen J; Yoshida T; Yokoi K; Hackett SF; Campochiaro PA
J Cell Physiol; 2009 Jun; 219(3):544-52. PubMed ID: 19142872
[TBL] [Abstract][Full Text] [Related]
18. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
[TBL] [Abstract][Full Text] [Related]
19. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.
Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J
Int J Mol Sci; 2015 Dec; 16(12):29900-10. PubMed ID: 26694358
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression.
Higuchi A; Ohashi K; Kihara S; Walsh K; Ouchi N
Circ Res; 2009 May; 104(9):1058-65. PubMed ID: 19342600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]